Pleurisy with pneumothorax due to CAM-resistant MAC lung disease

Respirol Case Rep. 2022 Jun 14;10(7):e0993. doi: 10.1002/rcr2.993. eCollection 2022 Jul.

Abstract

A 72-year-old man received rifampicin, ethambutol and sitafloxacin to treat clarithromycin (CAM)-resistant Mycobacterium avium complex (MAC) lung disease. He was admitted because of fever. Pneumothorax and pleural effusion were present in the right lung, and a new consolidation appeared in the right upper lobe. Based on positive culture of the pleural effusion for CAM-resistant M. avium and findings on chest computed tomography, he was diagnosed with pleurisy due to M. avium, with rupture of the subpleural lung parenchymal lesion into the pleural space. Additional treatment with streptomycin (SM) improved the patient's high-grade fever. SM might be effective for pleurisy caused by CAM-resistant MAC lung disease.

Keywords: Mycobacterium avium complex; clarithromycin; drug resistance; pleurisy; streptomycin.

Publication types

  • Case Reports